At the end of the 2020 Fiscal Year, AVH reported holding $73.84m in cash and cash equivalents. It also reached an agreement with the US armed services Institute of Regenerative Medicine for research funding of US $1.45m and there is also continuing funding from BARDA of about US $7.6m.
The likelihood of a capital raise, in my opinion, depends on how long it takes to find an effective vaccine for VOVID -19, which is financially impacting AVH, as it is with all businesses worldwide.
Shed a tear, page-27
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.94 |
Change
-0.090(2.97%) |
Mkt cap ! $207.0M | |||
| Open | High | Low | Value | Volume |
| $3.00 | $3.00 | $2.92 | $298.6K | 101.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3416 | $2.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.98 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| AVH (ASX) Chart |